BIIB i like long term calls i grabbed sep 50 at 2

[singh]

low risk but 200 dollar risk not bad

[FavStocks]

Beautiful chart on this one. I see a very nice consistent wave pattern here especially the last 6 months

These guys are on the FDA Calendar here in October. They have a drug Fampridine-SR for ME/MS. BIIB has a exclusive collaboration and license agreement to develop and commercialize Fampridine-SR Acorda Therapeutics, Inc. (NASDAQ:ACOR)